Phio Pharmaceuticals Corp.: Executive or director change
Phio Pharmaceuticals stockholders approved an equity incentive plan amendment and elected six directors at the 2026 Annual Meeting.
Neutral newsWhat happened
- Stockholders approved an amendment to the 2020 Long Term Incentive Plan increasing common shares available for issuance by 1,500,000 to a total of 2,452,017 shares.
The full interpretation is in the app
Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.
Read the full interpretation